Concept information
Preferred term
Sparteine
Type
-
mesh:Descriptor
Definition
- A quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype.
Broader concept
Entry terms
- 14703-10-7 (unspecified HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 24915-04-6
- 298897D62S
- 299-39-8 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 3599-17-5 (mono-HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 3D76XVF9R0
- 42808-46-8 (unspecified HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 446-95-7 ((7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer)
- 492-06-8 ((7R-(7alpha,7abeta,14alpha,14abeta))-isomer)
- 492-08-0
- 51799-26-9 (mono-HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 52670-59-4 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer)
- 6160-12-9 (sulfate[1:1].pentahydrate((7S-(7alpha,7aalpha,14alpha,14abeta))-isomer))
- 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-
- 72198-25-5 (unspecified HCl(7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 90-39-1 (Sparteine)
- GQ3J2TLZ7E
- L-Sparteine
- Sparteine, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer
- Sparteine, (-)-Isomer
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- biosynthesis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- physiology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
14703-10-7 (unspecified HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
24915-04-6
-
298897D62S
-
299-39-8 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
3599-17-5 (mono-HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
3D76XVF9R0
-
42808-46-8 (unspecified HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
446-95-7 ((7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer)
-
492-06-8 ((7R-(7alpha,7abeta,14alpha,14abeta))-isomer)
-
492-08-0
-
51799-26-9 (mono-HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
52670-59-4 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer)
-
6160-12-9 (sulfate[1:1].pentahydrate((7S-(7alpha,7aalpha,14alpha,14abeta))-isomer))
-
7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-
-
72198-25-5 (unspecified HCl(7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
90-39-1 (Sparteine)
-
GQ3J2TLZ7E
-
L-Spartéine
URI
http://data.loterre.fr/ark:/67375/JVR-P01MJBG5-L
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}